People with T2DM had a notably higher prevalance of testing for all markers (eg, in 2016 ALT measured in 68.8% of those with T2DM vs 15.3% and 21.9% of those with alcohol excess and obesity, respectively). This evidence concerns the gene GPT and obesity due to melanocortin 4 receptor deficiency.